Inventor
WENDT MICHAEL D
US40 patents
⚠️ This page may combine multiple inventors who share the name “WENDT MICHAEL D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE INC
20 patentsUS9174982B2Nov 3, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC38 citations98
US9315488B2Apr 19, 2016
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC13 citations92
US8952157B2Feb 10, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC22 citations91
US9303025B2Apr 5, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC11 citations84
US9125913B2Sep 8, 2015
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC10 citations84
US9073855B2Jul 7, 2015
BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9072748B2Jul 7, 2015
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9045420B2Jun 2, 2015
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9045444B2Jun 2, 2015
Apoptosis promoters
ABBVIE INC11 citations84
US8940737B2Jan 27, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC7 citations83
US10676485B2Jun 9, 2020
Macrocyclic MCL-1 inhibitors and methods of use
ABBVIE INC2 citations73
US9561231B2Feb 7, 2017
Pyridinone and pyridazinone derivatives
ABBVIE INC4 citations71
US11897864B2Feb 13, 2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations62
US11786519B2Oct 17, 2023
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations62
US9844547B2Dec 19, 2017
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC1 citations62
US9266877B2Feb 23, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC2 citations62
US9227963B2Jan 5, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC2 citations62
US8889675B2Nov 18, 2014
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC3 citations62
US9156856B2Oct 13, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations52
US9877958B2Jan 30, 2018
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC1 citations51
ABBOTT LAB
12 patentsUS7504512B2Mar 17, 2009
N-acylsulfonamide apoptosis promoters
ABBOTT LAB58 citations97
US6720338B2Apr 13, 2004
N-acylsulfonamide apoptosis promoters
ABBOTT LAB98 citations97
US6258822B1Jul 10, 2001
Urokinase inhibitors
ABBOTT LAB70 citations95
US8343967B2Jan 1, 2013
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBOTT LAB32 citations92
US6284796B1Sep 4, 2001
Ukokinase inhibitors
ABBOTT LAB20 citations92
US5891882AApr 6, 1999
Benzopyranopyrrole and benzopyranopyridine α-1 adenergic compounds
ABBOTT LAB29 citations92
US5597823AJan 28, 1997
Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists
ABBOTT LAB31 citations92
US7754886B2Jul 13, 2010
N-acylsulfonamide apoptosis promoters
ABBOTT LAB34 citations90
US7910742B2Mar 22, 2011
Survivin inhibitors
ABBOTT LAB9 citations82
US6376488B1Apr 23, 2002
Benzoxazine α-1 adrenergic compounds
ABBOTT LAB1 citations52
US7989656B2Aug 2, 2011
Biaryl carboxylic acid apoptosis promoters
ABBOTT LAB0 citations51
US7750004B2Jul 6, 2010
Apoptosis promoters
ABBOTT LAB0 citations51
BRUNCKO MILAN
4 patentsUS8586754B2Nov 19, 2013
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
BRUNCKO MILAN59 citations97
US8563735B2Oct 22, 2013
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
BRUNCKO MILAN72 citations97
US8546399B2Oct 1, 2013
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
BRUNCKO MILAN100 citations97
US8084607B2Dec 27, 2011
Apoptosis promoters
BRUNCKO MILAN43 citations93